cilengitide has been researched along with Laryngeal Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kan, X; Liu, M; Liu, Y; Lu, JG; Wang, JT | 1 |
1 other study(ies) available for cilengitide and Laryngeal Neoplasms
Article | Year |
---|---|
Cilengitide, a small molecule antagonist, targeted to integrin αν inhibits proliferation and induces apoptosis of laryngeal cancer cells in vitro.
Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Gene Expression Regulation, Neoplastic; Humans; In Vitro Techniques; Integrin alphaV; Laryngeal Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; RNA, Neoplasm; Snake Venoms | 2014 |